AbbVie (NYSE:ABBV) Upgraded by BNP Paribas to Hold Rating
BNP Paribas upgraded shares of AbbVie (NYSE:ABBV – Free Report) to a hold rating in a research note published on Thursday morning,Zacks.com reports. ABBV has been the subject of a number of other reports. Evercore ISI increased their price objective on AbbVie from $204.00 to $205.00 and gave the stock an “outperform” rating in a […]
BNP Paribas upgraded shares of AbbVie (NYSE:ABBV – Free Report) to a hold rating in a research note published on Thursday morning,Zacks.com reports. ABBV has been the subject of a number of other reports. Evercore ISI increased their price objective on AbbVie from $204.00 to $205.00 and gave the stock an “outperform” rating in a […]
